← Browse by Condition
Medical Condition
hypomagnesemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3, Phase 4
ClinicalMetric tracks all active clinical trials for hypomagnesemia sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3 1
Phase 4 1
Top Sponsors
1 trial
1 trial
Recruiting Clinical Trials
NCT05998863 Phase 3
Recruiting
EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
Enrollment
56 pts
Location
United States
Sponsor
University of Texas Southweste...
NCT03088852 Phase 4
Recruiting
Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards
Enrollment
330 pts
Location
Israel
Sponsor
Frieda Wolf
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology